Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA Approval Decline Continues, But Why?
Ongoing COVID-19 Disruptions Cited As Possible Cause
Jul 30 2021
•
By
Derrick Gingery
What does the decline in ANDA approvals and complete response letters issued say about the FDA generics program? • Source: Alamy
More from Generics
More from Products